TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
KLRA

Kailera Therapeutics, Inc.

Healthcare · Biotechnology

10.80$ +4.3% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet KLRA
Line item Q1 26 Q2 26
– +93.9%
– +75.2%
– +16.5%
– +76.6%
– +90.6%
– -91.2%
– +52.5%
– +2.2%
– +170.6%
– –
– –
– -13.3%

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?